Anti-CAPZA1

Y123253 by Applied Biological Materials Inc. (ABM) is a mouse monoclonal IgG1 antibody targeting full-length CAPZA1 (F-Actin Capping Protein Subunit Alpha-1), validated for Western blot at 1:1000 in Hela lysate and for ELISA. Affinity purified, 100 µg/100 µl in PBS with 0.02% sodium azide. MBP is a registered vendor for Howard Hughes Medical Institute, Vanderbilt University, MD Anderson Cancer Center, and Eurofins, among other leading institutes across the USA.